Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40HBS | ISIN: VGG7185A1369 | Ticker-Symbol:
NASDAQ
22.11.24
22:00 Uhr
4,620 US-Dollar
+0,030
+0,65 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PORTAGE BIOTECH INC Chart 1 Jahr
5-Tage-Chart
PORTAGE BIOTECH INC 5-Tage-Chart

Aktuelle News zur PORTAGE BIOTECH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
04.10.PORTAGE BIOTECH INC. - 6-K, Report of foreign issuer4
18.09.Pre-market Movers: Portage Biotech, Veea, Intuitive Machines, Applied Therapeutics, Galmed Pharmaceuticals1.221BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Portage Biotech Inc. (PRTG) is up over 179% at...
► Artikel lesen
PORTAGE BIOTECH Aktie jetzt für 0€ handeln
27.08.Portage Biotech Inc.: Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2024 and Business Update158WESTPORT, Conn., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. ("Portage" or the "Company") (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted...
► Artikel lesen
27.08.PORTAGE BIOTECH INC. - 6-K, Report of foreign issuer-
23.08.Pre-market Movers: Sequans Communications, Momentus, U-BX Technology, Portage Biotech, Pono Capital Two772BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 08.25 A.M. ET).In the Green Sequans Communications S.A. (SQNS) is up over 146%...
► Artikel lesen
16.08.Portage Biotech GAAP EPS of -$3.892
15.08.Portage Biotech Inc.: Portage Biotech Reports Fiscal Year-Ended March 31, 2024 Financial Results and Business Update156Exploration and evaluation of strategic alternatives continuePausing patient enrollment in the ADPORT-601 clinical trial (adenosine 2A and 2B inhibitors)Discontinuing the iNKT clinical trial for PORT-2...
► Artikel lesen
14.08.PORTAGE BIOTECH INC. - 20-F, Annual and transition report of foreign private issuers2
13.08.Portage Biotech stock plunges to 52-week low of $0.131
13.08.Portage Biotech announces 1-for-20 reverse stock split1
13.08.PORTAGE BIOTECH INC. - 6-K, Report of foreign issuer1
13.08.Portage Biotech to implement reverse stock split1
13.08.Portage Biotech Inc.: Portage Biotech Announces 1-for-20 Reverse Stock Split188WESTPORT, Conn., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. ("Portage" or the "Company") (NASDAQ: PRTG), a clinical-stage immuno-oncology company with a portfolio of novel multi-targeted...
► Artikel lesen
12.04.Portage Biotech Inc.: Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives553WESTPORT, Conn., April 12, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and...
► Artikel lesen
28.02.Portage Biotech Inc.: Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update176WESTPORT, Conn., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG) ("Portage" or the "Company"), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies...
► Artikel lesen
04.01.Portage Biotech Inc.: Portage Biotech Reports Business and Strategic Update265Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) --...
► Artikel lesen
28.11.23Portage Biotech Inc.: Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update184WESTPORT, Conn., Nov. 28, 2023 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company advancing novel multi-targeted therapies for use as monotherapy and...
► Artikel lesen
17 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1